ABCSG C06 (98)/QUASAR 2 Summary

Multicentre international study of capecitabine ± bevacizumab as adjuvant treatment of colon cancer.

Start 06/2007
End of randomising: 15.10.2010
Coordinating investigator: Thaler, Josef; Wels-Grieskirchen
Sample size: 2.240 international,
200 national
Design:
(Click to enlarge)
ABCSG-C06 Design